Brown R D, Prendiville P, Cain C
Mol Pharmacol. 1986 Jun;29(6):531-9.
Activation of alpha 1-adrenergic receptors in BC3H-1 muscle cells has been shown previously to mobilize intracellular Ca2+, which can be monitored as enhanced 45Ca2+ unidirectional efflux. We report here that histamine also stimulates 45Ca2+ efflux in these cells (Kact = 5.50 microM, nH = 0.94 +/- 0.04), reflecting mobilization of intracellular Ca2+ from a source similar to that accessed by alpha 1-adrenergic receptor activation. In addition, histamine stimulates substantial transmembrane 45Ca2+ influx into BC3H-1 cells. The actions of histamine are inhibited by the H1-selective antagonist, diphenhydramine (IC50 = 1.01 microM), but are unaffected by the H2-selective antagonist, cimetidine (1 nM-10 microM) indicating that histamine regulates cellular Ca2+ via a functional H1 receptor. The presence of independent receptor types which mobilize Ca2+ originating from common intracellular stores has been exploited in order to evaluate the determinants of receptor responsiveness following prior agonist exposure. After exposure with 45Ca2+ to achieve radioisotopic equilibrium, 30 min incubation with increasing concentrations of norepinephrine reduces to similar extents (30-40%) the unidirectional 45Ca2+ efflux responses to subsequent challenges by maximally effective concentrations of norepinephrine or histamine. The decrement in response following norepinephrine exposure appears to reflect an altered disposition of agonist-sensitive intracellular Ca2+, whereas the concentration dependence for alpha 1-adrenergic receptor activation remains unchanged. Prior exposure of cells to increasing concentrations of histamine also reduces the efflux response to norepinephrine challenge (approximately 30% decrease), whereas the response to subsequent histamine challenge is specifically and completely abolished. The loss of histamine responsiveness is accompanied by a marked shift in the concentration dependence for histamine receptor activation toward higher histamine concentrations. These results indicate that substantial alpha 1-receptor responsiveness is maintained following agonist exposure and that the observed reduction in response occurs distally to the receptor itself at some point common to alpha 1- and H1-receptor-effector coupling. By contrast, the H1-histamine receptor exhibits refractoriness, indicative of agonist-induced receptor desensitization.
先前已表明,BC3H - 1肌肉细胞中α1 - 肾上腺素能受体的激活可动员细胞内Ca2+,这可通过增强的45Ca2+单向外流来监测。我们在此报告,组胺也能刺激这些细胞中的45Ca2+外流(Kact = 5.50 microM,nH = 0.94 ± 0.04),这反映了细胞内Ca2+从与α1 - 肾上腺素能受体激活所涉及的来源相似的部位动员出来。此外,组胺还能刺激大量跨膜45Ca2+流入BC3H - 1细胞。组胺的作用受到H1选择性拮抗剂苯海拉明(IC50 = 1.01 microM)的抑制,但不受H2选择性拮抗剂西咪替丁(1 nM - 10 microM)的影响,这表明组胺通过功能性H1受体调节细胞内Ca2+。为了评估先前激动剂暴露后受体反应性的决定因素,利用了动员源自共同细胞内储存库的Ca2+的独立受体类型。在用45Ca2+暴露以达到放射性同位素平衡后,用浓度递增的去甲肾上腺素孵育30分钟,可使对随后最大有效浓度的去甲肾上腺素或组胺刺激的单向45Ca2+外流反应降低到相似程度(30 - 40%)。去甲肾上腺素暴露后反应的降低似乎反映了激动剂敏感的细胞内Ca2+的分布改变,而α1 - 肾上腺素能受体激活的浓度依赖性保持不变。细胞预先暴露于浓度递增的组胺也会降低对去甲肾上腺素刺激的外流反应(约降低30%),而对随后组胺刺激的反应则被特异性且完全消除。组胺反应性的丧失伴随着组胺受体激活浓度依赖性向更高组胺浓度的明显转变。这些结果表明,激动剂暴露后α1受体仍保持相当的反应性,并且观察到的反应降低发生在受体本身的远端,在α1和H1受体 - 效应器偶联的某个共同部位。相比之下,H1 - 组胺受体表现出不应性,表明激动剂诱导的受体脱敏。